BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34485443)

  • 1. Development and Evaluation of a Live Attenuated Egg-Based Camelpox Vaccine.
    Zhugunissov K; Kilibayev S; Mambetaliyev M; Zakarya K; Kassenov M; Abduraimov Y; Bulatov Y; Azanbekova M; Absatova Z; Abeuov K; Nurgaziev R; Renukaradhya GJ; Tabynov K
    Front Vet Sci; 2021; 8():721023. PubMed ID: 34485443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Field Trials of Live and Inactivated Camelpox Vaccines in Kazakhstan.
    Mambetaliyev M; Kilibayev S; Kenzhebaeva M; Sarsenkulova N; Tabys S; Valiyeva A; Muzarap D; Tuyskanova M; Myrzakhmetova B; Rametov N; Sarbassova A; Nurgaziev R; Kerimbayev A; Babiuk S; Zhugunissov K
    Vaccines (Basel); 2024 Jun; 12(6):. PubMed ID: 38932413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an Inactivated Camelpox Vaccine from Attenuated Camelpox Virus Strain: Safety and Protection in Camels.
    Zhugunissov K; Mambetaliyev M; Sarsenkulova N; Tabys S; Kenzhebaeva M; Issimov A; Abduraimov Y
    Animals (Basel); 2023 Apr; 13(9):. PubMed ID: 37174551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of a live attenuated camelpox vaccine from a local field isolate of the virus.
    Abdellatif MM; Ibrahim AA; Khalafalla AI
    Rev Sci Tech; 2014 Dec; 33(3):831-8. PubMed ID: 25812207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation and genetic characteristics of a Moroccan strain of Camel pox virus.
    Bamouh Z; Hamdi J; Elkarhat Z; Fellahi S; Omari Tadlaoui K; Watts DM; Fassi Fihri O; Elharrak M
    Vaccine; 2022 Oct; 40(45):6471-6480. PubMed ID: 36192275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a live cell culture camelpox vaccine.
    Hafez SM; al-Sukayran A; dela Cruz D; Mazloum KS; al-Bokmy AM; al-Mukayel A; Amjad AM
    Vaccine; 1992; 10(8):533-9. PubMed ID: 1621417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Camelpox: A brief review on its epidemiology, current status and challenges.
    Dahiya SS; Kumar S; Mehta SC; Narnaware SD; Singh R; Tuteja FC
    Acta Trop; 2016 Jun; 158():32-38. PubMed ID: 26902797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental camelpox infection in vaccinated and unvaccinated dromedaries.
    Wernery U; Zachariah R
    Zentralbl Veterinarmed B; 1999 Mar; 46(2):131-5. PubMed ID: 10216456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a live attenuated vaccine against Muscovy duck reovirus infection.
    Chen S; Lin F; Chen S; Hu Q; Cheng X; Jiang B; Zhu X; Wang S; Zheng M; Huang M
    Vaccine; 2018 Dec; 36(52):8001-8007. PubMed ID: 30420117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Another case of mistaken identity? Vaccinia virus in another live Camelpox vaccine.
    Saud Z; Butt TM
    Biologicals; 2020 May; 65():39-41. PubMed ID: 32334926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and efficacy of a novel live-attenuated QX-like nephropathogenic infectious bronchitis virus vaccine in China.
    Feng K; Xue Y; Wang J; Chen W; Chen F; Bi Y; Xie Q
    Vaccine; 2015 Feb; 33(9):1113-20. PubMed ID: 25636916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a live attenuated duck hepatitis A virus type 3 vaccine (strain SD70).
    Wu F; Lu F; Fan X; Pan Q; Zhao S; Sun H; Zhang J; Liu C; Chao J; Zhang X
    Vaccine; 2020 Jun; 38(30):4695-4703. PubMed ID: 32446833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rescue of a recombinant Newcastle disease virus expressing the green fluorescent protein].
    Ge JY; Wen ZY; Wang Y; Bao ED; Bu ZG
    Wei Sheng Wu Xue Bao; 2006 Aug; 46(4):547-51. PubMed ID: 17037052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful cross-protective efficacy induced by heat-adapted live attenuated nephropathogenic infectious bronchitis virus derived from a natural recombinant strain.
    Lim TH; Youn HN; Yuk SS; Kwon JH; Hong WT; Gwon GB; Lee JA; Lee JB; Lee SW; Song CS
    Vaccine; 2015 Dec; 33(51):7370-7374. PubMed ID: 26218899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an attenuated live vaccine candidate of duck Tembusu virus strain.
    He D; Zhang X; Chen L; Tang Y; Diao Y
    Vet Microbiol; 2019 Apr; 231():218-225. PubMed ID: 30955813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Recombinant La Sota Vaccine Strain Expressing Multiple Epitopes of Infectious Bronchitis Virus (IBV) Protects Specific Pathogen-Free (SPF) Chickens against IBV and NDV Challenges.
    Tan L; Wen G; Qiu X; Yuan Y; Meng C; Sun Y; Liao Y; Song C; Liu W; Shi Y; Shao H; Ding C
    Vaccines (Basel); 2019 Nov; 7(4):. PubMed ID: 31683905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolation of a new strain М-2020 of the camelpox virus (
    Zhugunissov КD; Mambetaliyev МА; Azanbekova МА; Kenzhebaeva МК; Kilibayev SS; Tuyskanova MS; Dzhapasheva AS; Omurtay AD; Tabys ST
    Vopr Virusol; 2022 Mar; 67(1):77-86. PubMed ID: 35293191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the safety and efficacy of an attenuated live vaccine based on highly virulent genotype 2b porcine epidemic diarrhea virus in nursing piglets.
    Jang G; Won H; Lee DU; Noh YH; Lee SC; Choi HW; Yoon IJ; Lee YJ; Sang Yoo H; Lee C
    Vet Microbiol; 2019 Apr; 231():120-128. PubMed ID: 30955799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of a live attenuated Rift Valley Fever recombinant arMP-12ΔNSm21/384 vaccine candidate for sheep, goats and calves.
    Boumart Z; Daouam S; Bamouh Z; Jazouli M; Tadlaoui KO; Dungu B; Bettinger G; Watts DM; Elharrak M
    Vaccine; 2019 Mar; 37(12):1642-1650. PubMed ID: 30773401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney Cell-Adapted Infectious Bronchitis ArkDPI Vaccine is Stable and Protective.
    Zegpi RA; Breedlove C; van Santen VL; Rasmussen-Ivey CR; Toro H
    Avian Dis; 2017 Jun; 61(2):221-228. PubMed ID: 28665723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.